Evidence map›Paper›PMID 37297754›Full record

ArticleHealthcare (Basel, Switzerland)2023

Cardiovascular Disease-Related Health Promotion and Prevention Services by Pharmacists in Saudi Arabia: How Well Are They Prepared?

Sirajudeen Shaik Alavudeen, Vigneshwaran Easwaran, Noohu Abdulla Khan, Krishnaraju Venkatesan, Premalatha Paulsamy, Abubakr Taha Mohammed Hussein, Mohammad Tarique Imam, Ziyad Saeed Almalki, Md Sayeed Akhtar

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sirajudeen Shaik AlavudeenDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.
Vigneshwaran EaswaranDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.
Noohu Abdulla KhanDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.
Krishnaraju VenkatesanDepartment of Pharmacology, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.
Premalatha PaulsamyCollege of Nursing, Mahalah Branch for Girls, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0001-5117-480X
Abubakr Taha Mohammed HusseinDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.
Mohammad Tarique ImamDepartment of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 16273, Saudi Arabia.ORCID 0000-0002-5991-6924
Ziyad Saeed AlmalkiDepartment of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 16273, Saudi Arabia.ORCID 0000-0003-1618-4142
Md Sayeed AkhtarDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.
King Khalid University · SAPrince Sattam Bin Abdulaziz University · SA

Funding

King Khalid University RGP.2/207/44
6 · The paper itself

Abstract

backgroundCardiovascular diseases (CVDs) have been identified as the leading reason for morbidity and mortality in Saudi Arabia. Pharmacists play a major role in CVD prevention and health promotion. We aimed to assess the knowledge, attitudes, and involvement of pharmacists in CVD prevention and evaluate the influence of continuing medical education in CVD-prevention services in Saudi Arabia.

methodA cross-sectional study was conducted to evaluate the involvement of pharmacists in CVD-related prevention services along with their knowledge and attitudes. A 34-item questionnaire was developed and distributed among the participants.

resultsA total of 324 responses were included in the study. More than 60% of pharmacists had provided counseling regarding the importance of healthy lifestyles and self-monitoring CVD risk factors. About half of the participants (49.1%) had never received any CVD-related continuing medical education. Overall, more than 60% of the participants reported positively towards their role in CVD prevention. Lack of time (66%) and lack of educational materials and tools (41%) were the top perceived barriers for providing CVD-prevention and health-promotion activities, followed by lack of skills in using tools (36%) and lack of privacy/space (33%).

conclusionsThe involvement of pharmacists in the prevention of CVD is limited in this study. Further education and capacity building are required to strengthen pharmacists' involvement in CVD-prevention and health-promotion activities.

Indexed as

attitudebarriercardiovascular diseasepharmacistspreventionSaudi Arabia

Identifiers

PMID37297754
PMCPMC10252446
OpenAlexW4379057572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.